Illimis Therapeutics’ Series B round was led by Korean venture capital firm DSC Investment. Seoul-based Illimis Therapeutics has raised 58 billion won ($42 million) to fund its research into ...

Apigenin is a chemical compound naturally found in plants such as parsley, chamomile, and celery. There’s been some interest ...

The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the drug discovery research ...

A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health issues like dementia ...

Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, explains how a focused GLP-1 task force and deep market insights are helping sponsors stand out in ...

Each year in the U.S., approximately 2.5 million people suffer traumatic brain injuries (TBIs). About 50,000 of these injuries will result in death, and more than 80,000 will lead to permanent ...

Dunedin Study researchers have developed a new tool that can tell how fast someone is aging by looking at a snapshot of their brain.Called ...

People who receive six or more prescriptions of gabapentin for lower back pain are at a significantly higher risk of dementia and mild cognitive impairment, a large new study suggests.

A new drug could one day revolutionize how stroke patients are treated by preventing further damage to the brain. Each year, some 795,000 people in the United States experience a stroke, the CDC ...

Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new study.